BioVie

#药闻简讯# $BioVie(BIVI)$ 在早期帕金森病中完成 SUNRISE-PD II 期试验的入组。
- SUNRISE-PD 试验的首份数据预计将在 2026 年上半年发布

$BioVie(BIVI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001520138-26-000052  Act: 34  Size: 3 MB 网页链接

$BioVie(BIVI)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001520138-25-000371  Act: 33  Size: 253 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000020  Size: 221 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000022  Size: 7 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000021  Size: 5 KB 网页链接

$BioVie(BIVI)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003311  Act: 33  Size: 1 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000019  Size: 5 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000017  Size: 7 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000018  Size: 5 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000023  Size: 5 KB 网页链接

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-26-000024  Size: 5 KB 网页链接